Price
No data yet.
Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.45
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
PPHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+15.38%Social Signal Score
Mentions (4)
- Newszacks.com·1d ago·Neutral
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on December 20, 2011.
View source ↗ - Newsfool.com·3d ago·Negative
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.
View source ↗ - Newsfool.com·25d ago·Negative
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a significantly higher dividend yield and a lower expense ratio than its counterpart.
View source ↗ - Newsfool.com·48d ago·Negative
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? VanEck Pharmaceutical ETF offers a lower-volatility profile and a higher 1.9% dividend yield compared to State Street SPDR S&P Biotech ETF. State Street SPDR S&P Biotech ETF provides broad exposure with 155 holdings, whereas VanEck Pharmaceutical ETF is concentrated in 26 major drugmakers.
View source ↗
Congress trades
No disclosed congressional trades in PPH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.